Delivery Order SPE2DB25D3012-SPE2DB25FWWDX
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,830.18 firm fixed-price contract is for the supply of Injectafer 750 mg/15 ml vial, a pharmaceutical product, with a performance period through August 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued up to $999,999,999 for delivering a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer, a 750 mg/15 mL injectable medication. The $2,414.43 firm fixed-price delivery order has a completion date of November 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. The $11,001.13 award is for the supply of Injectafer 750 mg/15 ml vials, a specialty pharmaceutical product, with a completion date of March 27, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,522.64 firm-fixed-price contract provides the injectable medication Injectafer 750 mg/15 ml vial, with a completion date of May 28, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which serves as a...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $23,850.63, is for the delivery of Injectafer 750 mg/15 ml vials. This is a firm fixed-price delivery order contract with a completion date of January 9, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Injectafer 750 mg/15 ml vials. The $10,756 firm fixed-price contract has a completion date of February 20, 2025 and is not set aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Injectafer 750 mg/15 ml vials. The contract has a ceiling value of $18,709.14 and a period of performance through January 8, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract with the DLA Troop Support Medical valued at...
- The Defense Logistics Agency awarded a $21,873.30 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Injectafer 750 mg/15 ml vials. This firm fixed-price, competitively awarded contract is scheduled for completion by August 11, 2025, with performance based in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, indicating AmerisourceBergen competed against other vendors to secure this pharmaceutical supply delivery. This delivery order...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Injectafer 750 mg/15 ml vials. The award, valued at $7,383.47, is a firm fixed-price contract with a completion date of July 17, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which covers a comprehensive range of pharmaceutical...
- This federal contract award to AmerisourceBergen Drug Corp is for the delivery of Injectafer 750 mg/15 ml vial, a specialty pharmaceutical product. The $8,837.40 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of August 7, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several large Indefinite Delivery Contracts (IDCs) with the DLA and Department of Justice...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWWDXDelivery Order
This is a $22,155.73 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the injectable medication Injectafer 750 mg/15 ml vial. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation covering similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.2k | 3/14/25 |